Authors
Latest:
The Cutaneous Connection: Intervening in AD Progression for Pediatric PatientsExplore the disease progression of atopic dermatitis and strategies to make a difference in patients' lives.
Latest:
Childhood burn care: A telemedicine success storyOne hospital leverages technology to reduce the stress of extensive, ongoing care on patients and families
Latest:
Eradicating actinic keratosis: Pros and consDr. Neal Bhatia shares his perspective on Actinic Keratosis from his Controversies session at the 23rd World Congress for Dermatology: pros and cons on routine eradication, trending populations, and modalities of treatment. learn more.
Latest:
Honey's use in skin therapyGiven the numerous types of honey and geographic variances of bee products and what is known already about honey’s use in skin therapy, it follows that there is likely untapped potential for dermatologic application, and more investigation is clearly warranted.
Latest:
Honey's use in skin therapyGiven the numerous types of honey and geographic variances of bee products and what is known already about honey’s use in skin therapy, it follows that there is likely untapped potential for dermatologic application, and more investigation is clearly warranted.
Latest:
Sonidegib offers new option for basal cell cancerA newly approved medication called sonidegib (Odomzo) gives physicians a second option in a class of medications designed to treat a small number of patients who suffer from locally advanced basal cell carcinoma and meet other criteria. Learn more
Latest:
Integrative and alternative treatments for seborrheic dermatitisEssential oils, aloe vera, supplements, diet, and other solutions may be of use for patients who request alternative or integrative treatments for seborrheic dermatitis.
Latest:
Maximizing the 2-Fold Benefits of Your Charitable DonationsMany dermatologists want to donate to charity while maximizing tax benefits, and certain tools can help achieve this.
Latest:
Technology advances cellulite treatmentWe finally have effective interventions that address the root cause of cellulite (fibrous tethers). Now, patient education and selection becomes paramount. Long horizontal lines and the infragluteal cleft or bulge, the so-called “banana-roll” cannot be corrected with these interventions. Prior to performing cellulite procedures we must impart this knowledge to our patients to ensure realistic expectations.
Latest:
Recognizing Key Differences Between Atopic Dermatitis and Prurigo NodularisGil Yosipovitch, MD, reviews differences including lesion appearance, cytokine pathways, treatment options, and more.
Latest:
Mitigating Alternative Topical Treatments: Ruxolitinib's Role in Atopic Dermatitis ManagementA dermatology expert reviews findings from a recently presented study on using other atopic dermatitis (AD) treatments within six months of initiating ruxolitinib cream. The expert assesses ruxolitinib's effectiveness and potential role in treatment, highlighting the need for further research on its long-term implications in AD management.
Latest:
Why Dermatologists Are Not Average InvestorsThis article compares physicians in general to average US investors in several key areas and examines how these factors affect a dermatologist’s approach to investing and wealth management.
Latest:
Teenagers and indoor tanningEpidemiological studies have shown a significant association between indoor tanning and melanoma. This risk especially pertains to exposure in childhood and adolescence, as these are periods of greater biological vulnerability to ultraviolet (UV) radiation.
Latest:
YOUR ASSET PROTECTION PLANWas this transaction done to save taxes or did it have another economic purpose? If there was such a purpose, the transaction stands; if it was only tax-motivated, it fails.
Latest:
Hidradenitis Suppurativa in Transgender and Gender-Diverse Patients and Hormone TherapyResearchers found that patients who initiated gender-affirming hormone therapy with testosterone were more likely to experience a worsening of their HS symptoms.
Latest:
Favorable Safety, Efficacy Data on Newer Acne Vulgaris TreatmentClascoterone cream 1% phase 3 results presented at meeting.
Latest:
FDA approves luliconazole for tinea pedisThe Food and Drug Administration has approved luliconazole (Luzu Cream, 1 percent, Valeant Pharmaceuticals) for the two-week, once-daily treatment of interdigital tinea pedis, tinea cruris, and tinea corporis, caused by the organisms Trichophyton rubrum and Epidermophyton floccosum, in patients ages 18 and older.
Latest:
Early intervention curbs atopic dermatitis in childrenEarly initiation of treatment for atopic dermatitis (AD) offers the best possibility for altering the natural course of the disease, increasing the odds that children might outgrow the problem, according to Elaine Siegfried, M.D., professor of pediatrics in dermatology, Saint Louis University Health Sciences Center, St. Louis.
Latest:
Noninvasive devices for lifting, tightening gaining momentumNew devices are hitting the market with claims of skin-tightening capabilities.
Latest:
Noninvasive devices for lifting, tightening gaining momentumNew devices are hitting the market with claims of skin-tightening capabilities.
Latest:
Dermatologic conditions can affect the mind, and vice versaAlthough dermatologic conditions most apparently affect the skin, dermatologists commonly encounter three types of psychodermatologic disorders where the mind and skin may interact, according to John Koo, M.D., professor and vice chairman, department of dermatology, University of California, San Francisco Medical Center.
Latest:
Letter to the editor: Checks,balances: Where should the pharmacist's loyalty lie?Norman Levine, M.D., as evidenced in his Sep. 1, 2008, Dermatology Times Commentary (Commentary: Pharmacists, insurers limit scope of practice, prescription choices) is an articulate, caring and excellent physician, and I commend him for taking care of patients with delusions of parasitosis, a disease many of his colleagues elect to refer.
Latest:
What's new in retirement planning?Defined benefit pension plans as well as cash balance plans are generating a lot of interest with medical practices, both large and small.
Latest:
A close look at best use, technique, history of the rubyLiterature review, best use, techniques for the ruby laser.
Latest:
Prior Authorizations process compromises ability to treat patients satisfactorilyThe Prior Authorizations process creates inconsistent application, physician dissatisfaction and opportunity for life-threatening adverse events for patients.
Latest:
Bringing up baby: Pediatric subspecialty recent marker for dermatologyThe certification of pediatric dermatology as a subspecialty is a relatively recent milestone in the field of dermatology.
Latest:
Dupilumab tames AD in difficult-to-treat patientsDupilumab given concomitantly with topical corticosteroids significantly improved signs and symptoms of atopic dermatitis (AD) in adults refractory to or intolerant of cyclosporine A, a study shows.
Latest:
Challenging AAD: Doctor disagrees on House bill 3200I was dismayed to learn that the elite leadership of the American Academy of Dermatology has hastily supported House Bill 3200.
Latest:
Examining Dr. Mohs: With no formal residency training, doctor devised revolutionary techniqueThe treatise on the "Evolution of Mohs" written by your senior staff correspondent John Jesitus and published in your July 2009 issue contains a very significant error. Frederick Mohs' professional life was not "general surgery's loss," for Dr. Mohs never was a surgeon (nor a dermatologist). I was informed he "completed an internship - most likely of the rotating kind - and then started his research and practice."
